Secondaries announced 4.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Alder BioPharmaceuticals
Symbol: ALDR
Price: Last trade $25.92
Trade Date: 4/7
Shares: 3.9 million
Underwriter(s) J.P. Morgan, Leerink Partners, Wells Fargo Securities
Rating=Subscription Needed